Zapata AI announces use of quantum-enhanced generative AI to generate novel KRAS inhibitors
Feb. 20, 2024
Zapata Computing Inc. (Zapata AI) scientists have demonstrated the first instance of a generative model running on quantum hardware outperforming state-of-the-art classical models in generating viable cancer drug candidates.